Nexterone approved for arrhythmias - ONA

Links shared publicly online about this topic.

  • 718
    total visits

Nexterone approved for arrhythmias - ONA

oncologynurseadvisor.com

Prism Pharmaceuticals announced that Nexterone (amiodarone HCl) Premixed Injection has been approved by the FDA for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy.

View full resource at oncologynurseadvisor.com

Tags: Heart Disease, Arrhythmia, Ventricular Fibrillation, Pharma, FDA, Antiarrhythmic Medication, Cordarone

  • Share

Most Recently Shared on November 18, 2010 at 2:42 pm By:

Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter

news-medical.net — “Boston Scientific Corporation today announced Health Canada approval of the Blazer Open-Irrigated Catheter, the Company's latest radiofrequency ablation (RFA) catheter designed to treat a variety of arrhythmias such as atrial fibrillation, atrial flutter, ventricular tachycardia and other supraventricular tachycardias.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on March 15, 2012 at 2:05 pm By:

NewsMedical News-Medical.Net Health News

Health Canada approves Boston Scientific's Blazer Open-Irrigated RFA Catheter: Boston Scientific Corporation tod... http://t.co/ZtVd5Sce

2 months ago...

Medical News: FDA Orders Safety Review of Pradaxa - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA said it will begin a safety review of reports of excess bleeding associated with dabigatran (Pradaxa), an oral direct thrombin inhibitor that is approved for prevention of strokeView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on January 10, 2012 at 1:34 am By:

Medical News: Public Citizen Calls on FDA to Nix Xarelto - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “The consumer group Public Citizen has asked the FDA not to approve rivaroxaban (Xarelto) for use in patients with atrial fibrillation because of safety and efficacy concerns.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 21, 2011 at 5:08 pm By:

Cryoablation used to successfully treat atrial fibrillation in Canada

sciencedaily.com — “The electrophysiology team at the Montreal Heart Institute used cryoablation (ablation using cold) to treat a patient suffering from atrial fibrillation, the most common form of cardiac arrhythmia, and one associated with significant morbidity. This was a first in Canada following the approval of the Arctic Front device by Health Canada.View full resource at sciencedaily.com

  • View Related
  • Share

Most Recently Shared on May 11, 2011 at 1:11 pm By:

HeartsHealth Heart Health Health News

ScienceDaily: Cryoablation used to successfully treat atrial fibrillation in Canada http://bit.ly/j0Cnu4 Full http://bit.ly/jy23lS

12 months ago...

Baxter nabs Prism's arrythmia drug in $338M buyout - FierceBiotech

fiercebiotech.com — “Just months after gaining an FDA approval for ready-to-use IV formulations of its anti-arrhythmic agent Nexterone, Prism Pharmaceuticals has sealed a $338 million buyout deal with Baxter Read more...View full resource at fiercebiotech.com

  • View Related
  • Share

Most Recently Shared on April 18, 2011 at 3:20 pm By:

FierceBiotech FierceBiotech Health News

Baxter nabs Prism's arrythmia drug in $338M buyout. http://bit.ly/eijgEe

1 year ago...

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection

drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 10:07 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection:... http://bit.ly/e5xFxU #drug

1 year ago...

Prism Pharmaceuticals Receives FDA Approval of Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection

drugs.com — “Nexterone (amiodarone HCl) is used to treat life-threatening ventricular fibrillation and ventricular tachycardia. Includes Nexterone side effects, interactions and indications.View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on November 22, 2010 at 9:51 pm By:

drugscom Drugs.com Health Site

FDA Approves Ready-to-Use Nexterone (Amiodarone HCl) Premixed Injection - http://bit.ly/eLpm0Y

1 year ago...

Medical News: Dabigatran: The Case of the Missing 110-mg Dose - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “The mystery surrounding the doses of dabigatran (Pradaxa) approved this week by the FDA has not yet been fully solved, but the FDA has provided a partial answer.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 9:00 pm By:

Medical News: Dabigatran: The Case of the Missing 110-mg Dose - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “The mystery surrounding the doses of dabigatran (Pradaxa) approved this week by the FDA has not yet been fully solved, but the FDA has provided a partial answer.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 21, 2010 at 8:08 pm By:

PattyGrace Patricia Grace Eldercare Expert

Dabigatran: The Case of the Missing 110-mg Dose: (MedPage Today) -- The mystery surrounding the doses of dabigatra... http://bit.ly/c4DcIZ

2 years ago...

Dabigatran approved for AF | theheart.org

theheart.org — “Latest developments and findings in Arrhythmia/EP and Electrophysiology studies from Heartwire news and prominent cardiologists.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 3:39 pm By:

theheartorg Shelley Wood Cardiology

theheart.org readers are jabbering about the dose choices in yesterday's dabigatran approval--join the fray: http://bit.ly/csLQNS

2 years ago...

Medical News: Dabigatran Wins FDA Nod for Stroke Prevention in Afib Patients - in Cardiovascular, Arrhythmias from MedPage Today

medpagetoday.com — “WASHINGTON -- The anticoagulant drug dabigatran (Pradaxa) can be marketed for preventing strokes and thrombosis in patients with atrial fibrillation, the FDA announced.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 2:06 am By:

SeanKhozin Sean Khozin, MD, MPH Doctor, Internist, and Physician

Dabigatran approved for stroke prevention in a-fib as an oral med alternative to warfarin with no need for monitoring http://bit.ly/bZPJ79

2 years ago...

Dabigatran approved for AF | theheart.org

theheart.org — “Latest developments and findings in Arrhythmia/EP and Electrophysiology studies from Heartwire news and prominent cardiologists.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on October 20, 2010 at 1:10 am By:

theheartorg Shelley Wood Cardiology

FDA approves dabigatran for stroke prevention, embolism, in AF patients: The long wait for an alternative to warfa... http://bit.ly/9aYYOm

2 years ago...

$10.5 Million Grant To Initiate Nationwide Clinical Trial Of Chest Pain Drug For Arrhythmias

medicalnewstoday.com — “A drug approved to treat chest pain is being tested as a potential treatment for ventricular arrhythmias, irregular heart rhythms that are associated with increased hospitalizations and death andView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 14, 2010 at 11:26 am By:

HeartsHealth Heart Health Health News

MedicalNewsToday: $10.5 Million Grant To Initiate Nationwide Clinical Trial Of Chest Pain: http://bit.ly/adk1Pq Full http://bit.ly/aYfhkG

2 years ago...

New IV antiarrhythmic drug approved in EU for rapid conversion of AF | theheart.org theheart.org: Arrhythmia/EP, Electrophysiology news and education

theheart.org — “Latest developments and findings in Arrhythmia/EP and Electrophysiology studies from Heartwire news and prominent cardiologists.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on September 9, 2010 at 9:47 pm By:

theheartorg Shelley Wood Cardiology

Vernakalant cleared in EU for conversion of AF to sinus rhythm: A novel intravenous drug, vernakalant, has been ap... http://bit.ly/aWNTaF

2 years ago...

Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval

news-medical.net — “Medtronic, Inc. today announced it received Health Canada approval for the Medtronic Ablation Frontiers Cardiac Ablation System, a novel radiofrequency ablation technology for the treatment of atrial fibrillation. AF is the most common heart arrhythmia that affects more than 250,000 Canadians and seven million people worldwide.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 26, 2010 at 5:23 pm By:

Stroke_News News-Medical.Net Health News

Stroke News: Medtronic Ablation Frontiers Cardiac Ablation System receives Health Canada approval: Medtronic, In... http://twurl.nl/8hglry

2 years ago...

Advertisement